泪道系统肿瘤保眼术后重建的手术与眼科结局
该回顾性研究分析了2008至2019年17例泪道系统肿瘤保眼切除后重建患者,其中2例复杂修复、6例局部皮瓣、9例游离皮瓣,均接受辅助放疗。游离皮瓣组伤口裂开和瘘管形成率(11%)低于其他技术(25%),但差异无统计学意义(P=0.45)。
要点
- 保眼术后重建可采用复杂修复、局部皮瓣或游离皮瓣,均可行。
- 游离皮瓣组伤口裂开和瘘管形成率11%,其他技术25%(P=0.45)。
- 游离皮瓣组睑外翻、角膜病变和视力下降率有降低趋势,但无统计学差异。
核心结论
- 保眼手术联合重建和辅助放疗是泪道系统肿瘤可行治疗方案,游离皮瓣重建结局可靠。
- 游离皮瓣与非显微重建在伤口裂开、瘘管、睑外翻、角膜病变和视力下降方面无统计学显著差异。
研究设计与样本
- 回顾性综述,纳入2008至2019年泪道系统肿瘤切除后重建患者17例。
- 2例复杂修复,6例局部皮瓣,9例游离皮瓣;所有患者接受辅助放疗。
- 中位随访19个月(范围5-126个月)。
主要发现
- 游离皮瓣组伤口裂开和瘘管形成率为11%,其他技术为25%(P=0.45)。
- 游离皮瓣组睑外翻发生率33%,非显微重建组50%(P=0.48)。
- 游离皮瓣组角膜病变发生率11%,非显微重建组38%(P=0.20)。
- 游离皮瓣组视力下降发生率56%,非显微重建组75%(P=0.40)。
临床怎么用
- 对于泪道系统肿瘤保眼切除后缺损,可考虑游离皮瓣重建以获得可靠结局。
- 需告知患者不同重建方式在并发症方面差异无统计学意义。
局限性
- 回顾性研究,样本量小(17例),随访时间范围大。
- 并发症差异均无统计学意义,可能受样本量限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Tumors involving the lacrimal drainage apparatus can be effectively treated with oncologic eye-sparing resection, immediate reconstruction, and adjuvant radiation. The extirpative technique is well described, whereas the reconstructive approach and outcomes are limited and largely anecdotal. The present study describes the largest series in the literature evaluating outcomes after reconstruction after globe-preserving oncologic resection. METHODS: A retrospective review was performed for all patients undergoing reconstruction after resection of lacrimal gland tumors from 2008 to 2019. Reconstruction and ophthalmologic outcomes were assessed. RESULTS: Of the 17 patients included, 2 underwent complex repair, 6 were reconstructed with a locoregional flap, and 9 underwent free flap reconstruction. All patients were treated with adjuvant radiation therapy. The median follow-up was 19 months (range, 5-126 months). Defects reconstructed with free flaps had lower rates of wound dehiscence and fistula formation compared with those reconstructed with other techniques (11% vs 25%, P = 0.45). Patients undergoing reconstruction with free tissue transfer also tended to have lower rates of ectropion, keratopathy and decreased visual acuity compared with those undergoing nonmicrosurgical reconstruction (33% vs 50%, P = 0.48; 11% vs 38%, P = 0.20; 56% vs 75%, P = 0.40, respectively). These differences were not statistically significant. CONCLUSIONS: This is the first study to compare reconstructive and functional outcomes of nonmicrosurgical reconstruction and microsurgical free tissue transfer in the setting of eye-sparing surgery for tumors of the lacrimal drainage apparatus. Although various reconstructive options are feasible, microsurgical free tissue transfer is often used at our center and is associated with reliable outcomes.
引用
- Olenczak JB, Ford JR, Mericli AF, et al. Surgical and Ophthalmologic Outcomes of Reconstruction in Patients Treated With Eye-Sparing Surgery and Radiation Therapy for Tumors of the Lacrimal Drainage Apparatus. Ann Plast Surg. 2021. PMID: 33555683. doi:10.1097/SAP.0000000000002563
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。